A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study
Titel:
A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study
Auteur:
Ross, P.J. Repana, D. Saunders, M. Wilson, R.H. Plummer, C.J. Summers, J. Higgins, F. Peacock, J. Harari, D. Bridgewater, J.